BROOKSNSEBrooks Laboratories Limited· PharmaceuticalsHighNeutral
Announced Fri, 6 Feb · 21:07 IST

Brooks Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+21.6%1-day move
₹61.45
prior close
₹62.99
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+2.4+1.6+1.6+21.6+25.8+24.5+24.3+20.6+24.1+2.4-5.4+17.1-22.8
Up moveDown movePending
AI summary

Brooks Laboratories Limited has filed its quarterly financial results with the Exchange for the period ended December 31, 2025. The full set of numbers — including revenue, profit after tax, margins, and any auditor remarks — was not included in the headline text and would need to be reviewed from the actual results PDF or XBRL filing. As this is only a submission intimation, no specific financial metrics are visible from the provided announcement.

Likely market impact

The filing itself is a routine compliance disclosure and does not by itself move the stock. Investors should look at the actual results (revenue, PAT, margins, and any auditor qualifications) to judge the company's performance for the quarter.